Öcal, Osman
Rössler, Daniel
Gasbarrini, Antonio
Berg, Thomas
Klümpen, Heinz-Josef
Bargellini, Irene
Peynircioglu, Bora
van Delden, Otto
Schulz, Christian
Schütte, Kerstin
Iezzi, Roberto
Pech, Maciej
Malfertheiner, Peter
Sangro, Bruno
Ricke, Jens
Seidensticker, Max http://orcid.org/0000-0002-2481-5410
Funding for this research was provided by:
sirtex
bayer healthcare
Ludwig-Maximilians-Universität München
Article History
Received: 28 June 2021
Accepted: 11 September 2021
First Online: 20 September 2021
Declarations
:
: Maciej Pech: Grants: Sirtex, Bayer; Personal fees: Sirtex. Peter Malfertheiner: Grants: Bayer, Sirtex. Bruno Sangro: Personal fees: Sirtex, BTG, Bayer, BMS, Astra Zeneca, Eli Lilly, Merck, Novartis, Terumo, Adaptimmune; Non-financial support: Sirtex, BMS, outside the submitted work. Jens Ricke: Grants: Sirtex, Bayer; Personal fees: Sirtex, Bayer. Max Seidensticker: Personal fees: Bayer, Sirtex.
: The study protocol was approved by the competent authorities as well as the institutional review board of all participating centers, and all patients gave written informed consent.